Home › ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product
 

Keywords :   


ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product

2013-10-23 13:30:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX (Zoster Vaccine Live), the company's vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product. Language: English Contact: Media:MerckCaroline Lappetito, (267) 305-7639 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: product usa live prix

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »